<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=1200, user-scalable=yes, initial-scale=0.4, minimum-scale=0.1">
    <title>Quetiapine (Seroquel) - Complete Profile</title>
    <link rel="stylesheet" href="/Dyo-s-Dubious-Domain/style.css">
    <link rel="icon" type="image/svg+xml" href="/Dyo-s-Dubious-Domain/assets/logo.svg">
    <script>
        // Set base path for JavaScript files to use
        window.SITE_BASE_PATH = '/Dyo-s-Dubious-Domain/';
        
        // Force desktop behavior by overriding mobile detection
        window.isMobile = false;
        window.isDesktop = true;
        
        // Override any mobile detection functions
        if (window.matchMedia) {
            const originalMatchMedia = window.matchMedia;
            window.matchMedia = function(query) {
                // Force desktop media queries to always match for min-width
                // and mobile queries to never match
                if (query.includes('max-width') && (query.includes('768px') || query.includes('480px'))) {
                    return { matches: false, addListener: function() {}, removeListener: function() {} };
                }
                if (query.includes('min-width')) {
                    return { matches: true, addListener: function() {}, removeListener: function() {} };
                }
                return originalMatchMedia.call(this, query);
            };
        }
    </script>
</head>

<body class="
  
  
  
  ">
    <header class="page-header">
  <div class="container">
    <div class="page-header__content">
      <div class="logo-container">
        <a href="/Dyo-s-Dubious-Domain/" class="site-title">Dyo's Dubious Domain</a>
      </div>
      
      <nav>
        <ul role="list" class="nav-list flex-group">
          <li>
            <a href="/Dyo-s-Dubious-Domain/">Home</a>
          </li>
          <li>
            <a href="/Dyo-s-Dubious-Domain/dyos-domain/">Dyo's Domain</a>
          </li>
          <li>
            <a href="/Dyo-s-Dubious-Domain/about/">About</a>
          </li>
          <li>
            <a href="/Dyo-s-Dubious-Domain/profile/">My Profile</a>
          </li>
         
        </ul>
      </nav>
    </div>
    
    <!-- Search Bar - Now underneath header -->
    <div class="search-container">
      <input type="text" id="search-input" placeholder="Search substances..." class="search-input" />
      <div id="search-results" class="search-results" style="display: none;"></div>
    </div>
  </div>
</header>

    <main>
      
<div class="substance-profile-header">
  <div class="container">
    <nav class="breadcrumb">
      <a href="/dyos-domain/">Dyo's Domain</a> ‚ÜÅE<a href="/dyos-domain/depressants/">Depressants</a> ‚ÜÅE<span>Quetiapine</span>
    </nav>
    
    <div class="substance-hero">
      <div class="substance-info">
        <h1>üíä Quetiapine</h1>
        <h2 class="chemical-name">Quetiapine fumarate</h2>
        
        <!-- Add to Profile Button -->
        <button id="add-to-profile-btn" class="add-to-profile-btn not-in-profile" 
                data-substance="Quetiapine" 
                data-category="Depressants" 
                data-chemical="Quetiapine fumarate">
          + Add to My Profile
        </button>
        
        <div class="alternative-names">
          <h3>Alternative Names & Slang</h3>
          <div class="names-grid">
            <span class="name pharmaceutical">Seroquel</span>
            <span class="name pharmaceutical">Quetiapine</span>
            <span class="name street">Quell</span>
            <span class="name street">Susie-Q</span>
            <span class="name street">Baby heroin</span>
            <span class="name street">Suzy</span>
            <span class="name street">Q-ball</span>
            <span class="name street">Sleepeasy</span>
            <span class="name street">Zombie pills</span>
            <span class="name pharmaceutical">Seroquel XR</span>
            <span class="name street">Ket</span>
            <span class="name street">Quell pills</span>
          </div>
        </div>
        
        <div class="substance-meta-large">
          <span class="category depressant">Depressant</span>
          <span class="legal-status prescription">Prescription</span>
          <span class="duration long">6-12 hours</span>
        </div>
      </div>
      
      <div class="substance-visual">
        <div class="substance-image">
          <img src="/Dyo-s-Dubious-Domain/assets/substances/quetiapine.jpg" alt="Seroquel tablets" class="substance-photo">
        </div>
        <div class="molecule-structure">
          <div class="structure-placeholder">
            <p>Molecular structure: C‚ÇÇ‚ÇÅH‚ÇÇ‚ÇÖN‚ÇÉO‚ÇÇS</p>
          </div>
        </div>
      </div>
    </div>
  </div>
</div>

<div class="container">
  
  <div class="profile-grid">
    
    <div class="profile-section identification">
      <h3>üîç Physical Identification</h3>
      <div class="identification-info">
        <div class="pure-form">
          <h4>Pharmaceutical Seroquel</h4>
          <ul>
            <li><strong>25mg tablets:</strong> Peach, round, film-coated with "SEROQUEL 25" imprint</li>
            <li><strong>100mg tablets:</strong> Yellow, round, film-coated with "SEROQUEL 100" imprint</li>
            <li><strong>200mg tablets:</strong> White, round, film-coated with "SEROQUEL 200" imprint</li>
            <li><strong>300mg tablets:</strong> White, capsule-shaped with "SEROQUEL 300" imprint</li>
            <li><strong>XR formulation:</strong> Extended-release tablets in various strengths</li>
          </ul>
        </div>
        
        <div class="street-forms">
          <h4>Common Presentations</h4>
          <ul>
            <li><strong>Immediate release:</strong> Most commonly abused formulation</li>
            <li><strong>Extended release (XR):</strong> Harder to abuse, designed for once-daily dosing</li>
            <li><strong>Generic versions:</strong> Various manufacturers with different appearances</li>
            <li><strong>Crushed powder:</strong> Sometimes snorted or injected (dangerous)</li>
          </ul>
        </div>
        
        <div class="adulterants-warning">
          <h4>‚ö†ÔøΩEÔøΩESafety Concerns</h4>
          <p><strong>Prescription diversion:</strong> Commonly stolen from patients or bought illegally</p>
          <p><strong>Counterfeit pills:</strong> May contain unknown substances or incorrect doses</p>
          <p><strong>Injection risks:</strong> Tablets not designed for IV use cause severe tissue damage</p>
        </div>
      </div>
    </div>
    
    <div class="profile-section dosage">
      <h3>üíä Dosage Guidelines</h3>
      <div class="dosage-chart">
        <div class="dose-range threshold">
          <span class="range-label">Threshold</span>
          <span class="dose-amount">12.5-25mg</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range light">
          <span class="range-label">Light</span>
          <span class="dose-amount">25-50mg</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range common">
          <span class="range-label">Common</span>
          <span class="dose-amount">50-100mg</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range strong">
          <span class="range-label">Strong</span>
          <span class="dose-amount">100-200mg</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range heavy">
          <span class="range-label">Heavy</span>
          <span class="dose-amount">200mg+</span>
          <div class="dose-bar"></div>
        </div>
      </div>
      
      <div class="dosage-details">
        <h4>Dosage Considerations</h4>
        <ul>
          <li><strong>Medical doses:</strong> Schizophrenia 400-800mg daily, bipolar 300-800mg daily</li>
          <li><strong>Sleep abuse:</strong> Typically 25-100mg for sedative effects</li>
          <li><strong>Recreational abuse:</strong> 100-400mg for euphoric effects</li>
          <li><strong>Tolerance:</strong> Develops rapidly to sedative effects</li>
          <li><strong>Elderly sensitivity:</strong> Much more sensitive, lower doses required</li>
          <li><strong>First-time users:</strong> Extremely sensitive - start with 12.5-25mg maximum</li>
        </ul>
      </div>
      
      <p class="dosage-note"><strong>Critical Warning:</strong> Quetiapine can cause severe metabolic changes, tardive dyskinesia, and sudden cardiac death. Medical supervision is essential for any regular use.</p>
    </div>

    <div class="profile-section effects">
      <h3>‚ú® Effects Profile</h3>
      
      <div class="effects-timeline">
        <h4>Timeline (Immediate Release)</h4>
        <div class="timeline-item">
          <span class="time">T+0:30-1:00</span>
          <span class="effect">Onset - drowsiness, mild euphoria</span>
        </div>
        <div class="timeline-item">
          <span class="time">T+1:00-4:00</span>
          <span class="effect">Peak - intense sedation, potential euphoria</span>
        </div>
        <div class="timeline-item">
          <span class="time">T+4:00-8:00</span>
          <span class="effect">Plateau - continued sedation, grogginess</span>
        </div>
        <div class="timeline-item">
          <span class="time">T+8:00-24:00</span>
          <span class="effect">Comedown - hangover, cognitive impairment</span>
        </div>
      </div>

      <div class="effects-categories">
        <div class="effect-category positive">
          <h4>‚úÅESought Effects</h4>
          <ul>
            <li>Powerful sedation and sleep induction</li>
            <li>Anxiety relief</li>
            <li>Euphoria (at higher doses)</li>
            <li>Emotional blunting</li>
            <li>Pain relief (indirect)</li>
            <li>Alcohol withdrawal relief</li>
          </ul>
        </div>
        
        <div class="effect-category negative">
          <h4>‚ùÅEDangerous Side Effects</h4>
          <ul>
            <li><strong>Severe sedation</strong> and "zombie-like" state</li>
            <li>Metabolic syndrome (diabetes, weight gain)</li>
            <li>Tardive dyskinesia (irreversible movement disorder)</li>
            <li>Neuroleptic malignant syndrome (potentially fatal)</li>
            <li>Prolonged QT interval (cardiac risk)</li>
            <li>Severe cognitive impairment</li>
            <li>Extrapyramidal symptoms</li>
            <li>Prolactin elevation</li>
          </ul>
        </div>
      </div>
    </div>

    <div class="profile-section pharmacology">
      <h3>üß† Pharmacology & Neuroscience</h3>
      <div class="pharma-details">
        <h4>Primary Mechanism of Action</h4>
        <p>Quetiapine is an atypical antipsychotic that acts as an antagonist at multiple neurotransmitter receptors. Its unique pharmacological profile includes strong antihistamine (H1) activity responsible for sedation, 5-HT2A antagonism contributing to antipsychotic effects, and moderate dopamine D2 antagonism. The sedative and euphoric effects sought in abuse come primarily from histamine and adrenergic receptor antagonism.</p>
        
        <h4>Detailed Receptor Pharmacology</h4>
        <div class="receptor-table">
          <div class="receptor-row">
            <span class="receptor">Histamine H1</span>
            <span class="affinity">Very High</span>
            <span class="function">Sedation, weight gain</span>
          </div>
          <div class="receptor-row">
            <span class="receptor">5-HT2A</span>
            <span class="affinity">High</span>
            <span class="function">Antipsychotic effects</span>
          </div>
          <div class="receptor-row">
            <span class="receptor">Œ±1-Adrenergic</span>
            <span class="affinity">High</span>
            <span class="function">Orthostatic hypotension</span>
          </div>
          <div class="receptor-row">
            <span class="receptor">Dopamine D2</span>
            <span class="affinity">Moderate</span>
            <span class="function">Antipsychotic, motor effects</span>
          </div>
          <div class="receptor-row">
            <span class="receptor">5-HT2C</span>
            <span class="affinity">Moderate</span>
            <span class="function">Weight gain, glucose dysregulation</span>
          </div>
        </div>

        <h4>Metabolism & Pharmacokinetics</h4>
        <div class="metabolism-details">
          <p><strong>Primary pathway:</strong> Hepatic metabolism via CYP3A4</p>
          <p><strong>Active metabolite:</strong> N-desalkylquetiapine (norquetiapine) - significant activity</p>
          <p><strong>Half-life:</strong> 6-7 hours (IR), 7-12 hours (XR formulation)</p>
          <p><strong>Bioavailability:</strong> 73% oral administration</p>
          <p><strong>Peak plasma:</strong> 1-2 hours (IR), 6 hours (XR)</p>
          <p><strong>Protein binding:</strong> 83% bound to plasma proteins</p>
          <p><strong>Food effects:</strong> High-fat meals increase absorption significantly</p>
        </div>

        <h4>Unique Pharmacological Properties</h4>
        <ul>
          <li><strong>Dose-dependent receptor occupancy:</strong> Low doses primarily antihistamine, higher doses antidopaminergic</li>
          <li><strong>Fast dissociation from D2:</strong> Lower risk of tardive dyskinesia than typical antipsychotics</li>
          <li><strong>Metabolic disruption:</strong> Severe effects on glucose and lipid metabolism</li>
          <li><strong>Active metabolite effects:</strong> Norquetiapine has norepinephrine reuptake inhibition</li>
          <li><strong>Biphasic sleep effects:</strong> Initial sedation followed by REM sleep disruption</li>
          <li><strong>Abuse potential:</strong> Unique among antipsychotics due to euphoric effects</li>
        </ul>

        <h4>Serious Medical Complications</h4>
        <div class="neurotoxicity-info">
          <p><strong>Metabolic syndrome:</strong> Rapid onset of diabetes, weight gain, and dyslipidemia</p>
          <p><strong>Tardive dyskinesia:</strong> Irreversible movement disorder with chronic use</p>
          <p><strong>Neuroleptic malignant syndrome:</strong> Potentially fatal hyperthermia and muscle rigidity</p>
          <p><strong>Cardiac effects:</strong> QT prolongation increasing sudden cardiac death risk</p>
        </div>
      </div>
    </div>

    <div class="profile-section safety">
      <h3>‚ö†ÔøΩEÔøΩESafety & Harm Reduction</h3>
      
      <div class="safety-grid">
        <div class="safety-item critical">
          <h4>üö® Critical Warnings</h4>
          <ul>
            <li><strong>Sudden cardiac death:</strong> Especially in elderly or with heart conditions</li>
            <li><strong>Diabetic ketoacidosis:</strong> Can develop rapidly, even in non-diabetics</li>
            <li><strong>Neuroleptic malignant syndrome:</strong> Medical emergency with high mortality</li>
            <li><strong>Severe sedation:</strong> Risk of falls, accidents, aspiration</li>
            <li><strong>Withdrawal seizures:</strong> Dangerous discontinuation syndrome</li>
          </ul>
        </div>
        
        <div class="safety-item precautions">
          <h4>üõ°ÔøΩEÔøΩEEssential Precautions</h4>
          <ul>
            <li>Regular blood glucose and lipid monitoring</li>
            <li>Avoid driving or operating machinery for 12+ hours</li>
            <li>Never inject tablets - causes severe tissue damage</li>
            <li>Gradual taper required to prevent withdrawal</li>
            <li>Monitor for movement disorders</li>
            <li>Have someone check on you during peak effects</li>
          </ul>
        </div>
      </div>

      <div class="contraindications">
        <h4>üö´ Absolute Contraindications</h4>
        <p><strong>Do not use if you have:</strong> Heart rhythm disorders, uncontrolled diabetes, severe liver disease, dementia, or are taking drugs that prolong QT interval. Extremely dangerous in elderly patients.</p>
      </div>
    </div>

    <div class="profile-section interactions">
      <h3>‚öóÔ∏ÅEDrug Interactions</h3>
      
      <div class="interaction-levels">
        <div class="interaction dangerous">
          <h4>üî¥ Dangerous Combinations</h4>
          <ul>
            <li><strong>Alcohol:</strong> Severe respiratory depression, cardiac arrest</li>
            <li><strong>Opioids:</strong> Life-threatening sedation and respiratory depression</li>
            <li><strong>Benzodiazepines:</strong> Dangerous CNS depression</li>
            <li><strong>QT-prolonging drugs:</strong> Fatal cardiac arrhythmias</li>
            <li><strong>CNS depressants:</strong> Compounded sedation and respiratory risk</li>
          </ul>
        </div>
        
        <div class="interaction risky">
          <h4>üü° High Risk</h4>
          <ul>
            <li><strong>CYP3A4 inhibitors:</strong> Dramatically increased levels and toxicity</li>
            <li><strong>Antihypertensives:</strong> Severe hypotension and falls</li>
            <li><strong>Diabetes medications:</strong> Unpredictable glucose effects</li>
            <li><strong>Other antipsychotics:</strong> Increased movement disorder risk</li>
          </ul>
        </div>
        
        <div class="interaction caution">
          <h4>üü† Use Extreme Caution</h4>
          <ul>
            <li><strong>Antihistamines:</strong> Enhanced sedation</li>
            <li><strong>Blood pressure medications:</strong> Orthostatic hypotension</li>
            <li><strong>Seizure medications:</strong> Altered seizure threshold</li>
          </ul>
        </div>
      </div>
    </div>

    <div class="profile-section legal">
      <h3>‚öñÔ∏ÅELegal Status</h3>
      <div class="legal-info">
        <div class="legal-jurisdictions">
          <div class="jurisdiction">
            <span class="country">United States</span>
            <span class="status">Prescription Only - No controlled schedule</span>
          </div>
          <div class="jurisdiction">
            <span class="country">United Kingdom</span>
            <span class="status">Prescription Only Medicine (POM)</span>
          </div>
          <div class="jurisdiction">
            <span class="country">European Union</span>
            <span class="status">Prescription required - Various national regulations</span>
          </div>
          <div class="jurisdiction">
            <span class="country">International</span>
            <span class="status">Prescription medication - Not internationally controlled</span>
          </div>
        </div>
        
        <div class="therapeutic-status">
          <h4>üè• Medical Uses</h4>
          <p>Quetiapine is FDA-approved for schizophrenia, bipolar disorder (manic and depressive episodes), and major depressive disorder (adjunctive treatment). Off-label use for insomnia is controversial due to serious side effects and abuse potential.</p>
        </div>
      </div>
    </div>

    <div class="profile-section history">
      <h3>üìö History & Development</h3>
      
      <div class="history-timeline">
        <div class="history-event">
          <span class="year">1985</span>
          <p>Developed by AstraZeneca as part of atypical antipsychotic research</p>
        </div>
        <div class="history-event">
          <span class="year">1997</span>
          <p>FDA approval for schizophrenia treatment</p>
        </div>
        <div class="history-event">
          <span class="year">2004</span>
          <p>Approval expanded to bipolar disorder</p>
        </div>
        <div class="history-event">
          <span class="year">2007</span>
          <p>Extended-release formulation (Seroquel XR) approved</p>
        </div>
        <div class="history-event">
          <span class="year">2009</span>
          <p>Reports of widespread off-label prescribing for sleep emerge</p>
        </div>
        <div class="history-event">
          <span class="year">2010s</span>
          <p>Street abuse becomes common due to sedative and euphoric effects</p>
        </div>
        <div class="history-event">
          <span class="year">Present</span>
          <p>Recognized as significant drug of abuse in prisons and psychiatric settings</p>
        </div>
      </div>

      <div class="cultural-impact">
        <h4>Abuse Pattern Evolution</h4>
        <p>Quetiapine abuse emerged in institutional settings (prisons, psychiatric hospitals) where it was seen as "safe" and non-controlled. The abuse spread to general populations seeking sleep aid alternatives, earning street names like "baby heroin" for its euphoric potential at higher doses.</p>
      </div>
    </div>

    <div class="profile-section research">
      <h3>üî¨ Current Research & Concerns</h3>
      
      <div class="research-areas">
        <div class="research-item">
          <h4>Metabolic Side Effects</h4>
          <p>Ongoing research into minimizing quetiapine's severe metabolic effects, including rapid-onset diabetes and massive weight gain that can exceed 50+ pounds.</p>
        </div>
        
        <div class="research-item">
          <h4>Abuse Potential Studies</h4>
          <p>Investigation into why quetiapine, unlike other antipsychotics, has significant abuse potential and euphoric effects, particularly when combined with other substances.</p>
        </div>
        
        <div class="research-item">
          <h4>Safer Sleep Alternatives</h4>
          <p>Research into safer alternatives for the widespread off-label use of quetiapine for insomnia, given its serious side effect profile.</p>
        </div>
        
        <div class="research-item">
          <h4>Withdrawal Syndrome</h4>
          <p>Studies characterizing quetiapine withdrawal syndrome, including rebound insomnia, anxiety, and potential seizures requiring careful medical management.</p>
        </div>
      </div>
    </div>

  </div>

  <div class="substance-resources">
    <h3>üìñ Safety Resources</h3>
    <div class="resources-grid">
      <div class="resource-item">
        <h4>Medical Emergency</h4>
        <ul>
          <li>Emergency services: Call 911 for severe sedation</li>
          <li>Poison control: 1-800-222-1222</li>
          <li><a href="https://www.samhsa.gov/">SAMHSA</a> - Crisis helpline</li>
          <li>Neuroleptic malignant syndrome is a medical emergency</li>
        </ul>
      </div>
      
      <div class="resource-item">
        <h4>Medical Information</h4>
        <ul>
          <li><a href="https://www.fda.gov/">FDA</a> - Official prescribing information</li>
          <li><a href="https://pubmed.ncbi.nlm.nih.gov/">PubMed</a> - Medical research</li>
          <li>Regular monitoring required for metabolic effects</li>
          <li>Gradual tapering protocols for discontinuation</li>
        </ul>
      </div>
      
      <div class="resource-item">
        <h4>Addiction Support</h4>
        <ul>
          <li><a href="https://www.na.org/">Narcotics Anonymous</a> - Support groups</li>
          <li><a href="https://www.samhsa.gov/find-treatment">SAMHSA Treatment Locator</a></li>
          <li>Prescription drug addiction treatment</li>
          <li>Psychiatric medication management</li>
        </ul>
      </div>
    </div>
  </div>

</div>


    </main>
     <div class="footer-divider"></div>
<footer class="site-footer">
  
</footer>




<footer class="site-footer">
  
  </svg>
    <img src="/Dyo-s-Dubious-Domain/assets/logo.svg" alt="My Logo" class="logo">
     <p>¬© 2025 Uwaniumnya. Highly Illegal.</p>
  </footer>

  

    <!-- Search Scripts -->
    <script src="/Dyo-s-Dubious-Domain/js/lunr.min.js"></script>
    <script src="/Dyo-s-Dubious-Domain/assets/js/search.js"></script>
    <script src="/Dyo-s-Dubious-Domain/assets/js/substance-integration.js"></script>
    
    <!-- Only load profile.js on profile page -->
    
    
    <!-- Only load interaction-checker.js on interaction checker page -->
    
</body>
</html>